Estimating the economic costs of skin cancer in New South Wales, Australia

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Doran, Christopher M ^a   Ling, Rod ^a   Byrnes, Joshua ^b   Crane, Melanie ^c,d   Searles, Andrew ^a   Perez, Donna ^c   Shakeshaft, Anthony ^e  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c CANCER INSTITUTE NSW   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Cost; Economic; Epidemiology; New South Wales; Skin cancer

Indexed keywords

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; NEW SOUTH WALES; SKIN NEOPLASMS;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COST OF ILLNESS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEW SOUTH WALES; SKIN NEOPLASMS;

EID: 84960502214     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2267-3     Document Type: Article

References (55)

1. American Cancer Society. Cancer Facts & Figures 2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf. Accessed January 31, 2013.
2. Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2012. Cancer series no. 74. Cat. No. CAN 70. Canberra: AIHW; 2012.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2: Cancer Incidence and Mortality Worldwide: IARC Cancer base No.10. Lyon, France: International Agency for Research on Cancer; 2010.
4. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283-7.
5. Staples MP, Elwood M, Burton RC, William JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. MJA. 2006;184:6-10.
6. Australian Bureau of Statistics. Causes of death Cat. No. 3303.0. Canberra: ABS; 2013.
7. International Agency for Research on Cancer. World Cancer Report 2014. Geneva: WHO; 2014.
8. Cancer Council Australia. Australian Cancer Network Melanoma Guidelines Revision Working Party, Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Wellington Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group; 2008.
9. National Cancer Control Initiative. The 2002 National Non-Melanoma Skin Cancer Survey. A report by the NCCI Non-melanoma skin cancer working groups. Melbourne: NCCI; 2003.
10. Cancer Council Australia. Basal cell carcinoma, squamous cell carcinoma (and related lesions) - a guide to clinical management in Australia. Sydney: Cancer Council Australia and Australian Cancer Network; 2008.
11. Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol. 2010;146(3):279-82.
12. Australian Institute of Health and Welfare. Cancer incidence projections: Australia, 2011 to 2020, vol. Cancer Series no. 66. Cat. No. CAN 62. Canberra: AIHW; 2012.
13. Aitken R, Morrell S, Barraclough H, Baker D, Clements M, Jelfs P, et al. Cancer incidence and mortality projections in New South Wales, 2007 to 2011. Sydney: Cancer Institute NSW; 2008.
14. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. ANZJPH. 2005;29(4):383-6.
15. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20(4):417-35.
16. Davis KL, Mitra D, Kotapati S, Ibrahim R, Wolchok JD. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database. Appl Health Econ Health Policy. 2009;7(1):31-41.
17. Ekwueme DU, Guy GP, Li C, Rim SH, Parelkar P, Chen SC. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S133-43.
18. Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER) - Medicare data. Arch Dermatol. 2010;146(3):249-56.
19. Pereira de Souza RJ, Mattedi AP, Correa MP, Rezende ML, Ferreira AC. An estimate of the cost of treating non-melanoma skin cancer in the state of Sao Paulo, Brazil. An Bras Dermatol. 2011;86(4):657-62.
20. Augustin M, Blome C, Rustenbach SJ, Reusch M, Radtke M. Routine skin cancer screening in Germany: First data on the impact on health care in dermatology. J Dtsch Dermatol Ges. 2010;8(9):674-80.
21. Leiter U, Marghoob AA, Lasithiotakis K, Eigentler TK, Meier F, Meisner C, et al. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma. Melanoma Res. 2009;19(1):50-7.
22. Alexandrescu DT. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatol Online J. 2009;15(11):1.
23. Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65-72.
24. Chevalier J, Bonastre J, Avril M-F. The economic burden of melanoma in France: assessing healthcare use in a hospital setting. Melanoma Res. 2008;18(1):40-6.
25. Chen JG, Fleischer AB, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035-8.
26. Guy G, Ekwueme D, Tangka F, Richardson L. Melanoma treatment costs: a systematic review of the literature, 1990-2011. Am J Prev Med. 2012;43(5):537-45.
27. Guy G, Ekwueme D. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics. 2011;29(10):863-74.
28. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity Costs of Cancer Mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100(24):1763-70. doi: 10.1093/jnci/djn384.
29. Tinghog G, Carlsson P, Synnerstad I, Rosdahl I. Societal cost of skin cancer in Sweden in 2005. Acta Derm-Venereol. 2008;88(5):467-73.
30. O'Dea D. The costs of skin cancer to New Zealand. Cancer Society of New Zealand: Wellington; 2009.
31. Morris S, Cox B, Bosanquet N. Cost of skin cancer in England. Eur J Health Econ. 2009;10(3):267-73.
32. Eriksson T, Tinghög G. Societal cost of skin cancer in Sweden in 2011. Acta Derm Venereol. 2015;95(3):347-8.
33. Cancer Institute New South Wales. NSW skin cancer prevention strategy 2012-15. Sydney: Cancer Institute NSW; 2012.
34. Drummond M, Torrance G, O Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2005.
35. Cancer Institute New South Wales. NSW Central Cancer Registry Data Access. Sydney: CINSW; 2013. http://www.cancerinstitute.org.au/data-and-statistics/cancer-registries/nsw-central-cancer-registry-data-access.
36. Australian Bureau of Statistics. Estimated resident population, by age and sex. Catalogue no. 3201.0. Canberra: ABS; 2013.
37. Marks R, Staples MP, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer. 1993;53:585-90.
38. Australian Institute of Health and Welfare. Non-melanoma skin cancer, General practice consultations, hospitalisation and mortality. Cat. No. 39. Canberra: AIHW; 2008.
39. Sax Instittute. 45 and Up Study. Sydney: Sax Instittute; 2013. https://www.saxinstitute.org.au/our-work/45-up-study/. Accessed June 2012.
40. Australian Bureau of Statistics. NSW Health Department, admitted patient data collection. Cat. No. 1368.1. Canberra: ABS; 2013.
41. Australian Government Department of Human Services. Pharmaceutical Benefits Scheme (PBS). Canberra: Australian Government; 2013. http://www.pbs.gov.au/pbs/home. Accessed June 2012.
42. Australian Government Department of Human Services. Medicare Benefits Schedule. Canberra: Australian Government; 2013. http://www.mbsonline.gov.au/. Accessed June 2012.
43. Government of New South Wales. Registry of Births, Deaths and Marriages (RBDM). Sydney: NSW Government; 2013. http://www.bdm.nsw.gov.au/. Accessed June 2012.
44. World Health Organisation. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: WHO; 2013. http://apps.who.int/classifications/icd10/browse/2010/en. Accessed June 2012.
45. Australian Institute of Health and Welfare. Health expenditure Australia 2010-11. Health and welfare expenditure series no. 47. Cat. No. HWE 56. Canberra: AIHW; 2012.
46. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD. The burden of disease and injury in Australia 2003. PHE 82. Canberra: AIHW; 2007.
47. Single E, Collns D, Easton B, Harwood HJ, Lapsley H, Kopp P, et al. International guidelines for estimating the costs of substance abuse. Geneva: World Health Organisation; 2003.
48. Australian Bureau of Statistics. Average weekly earnings. Cat. No. 6302.0. Canberra: ABS; 2013.
49. Australian Bureau of Statistics. Labour force. Cat. No. 6202.0. Canberra: ABS; 2013.
50. Safe Work Australia. National hazard exposure worker surveillance: exposure to direct sunlight and the provision of sun exposure controls in Australian workplaces. Canberra: Commonwealth of Australia; 2010.
51. Economics A. The economic value of informal care in 2010: Report for Carers Australia. Access Economics: Canberra; 2010.
52. Barzilai DA, Koroukian SM, Neuhauser D, Cooper KD, Rimm AA, Cooper GS. The sensitivity of Medicare data for identifying incident cases of invasive melanoma (United States). Cancer Causes Control. 2004;15(2):179-84.
53. Styperek A, Kimball AB. Malignant melanoma: The implications of cost for stakeholder innovation. Am J Pharm Ben. 2012;4(2):66-76.
54. Australian Institute of Health and Welfare. Health system expenditures on cancer and other neoplasms in Australia, 2000-2001, in Health and Welfare Expenditure Series no. 22. Canberra: AIHW; 2005.
55. Mathers C, Penm R, Sanson-Fisher R, Carter R, Campbell E. Health system costs of cancer in Australia 1993-94. AIHW Cat. No. HWE 4. Canberra: AIHW and National Cancer Countrol Intitiative; 1998.